Vivani Medical, Inc. (VANI)
NASDAQ: VANI · Real-Time Price · USD
1.260
-0.030 (-2.33%)
Nov 4, 2024, 4:00 PM EST - Market closed

Vivani Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2006 2005 - 2004
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '06 2005 - 2004
Revenue
-----1.81
Upgrade
Revenue Growth (YoY)
------21.06%
Upgrade
Selling, General & Admin
8.88105.372.322.38-
Upgrade
Research & Development
16.3916.9714.17116.87-
Upgrade
Operating Expenses
25.2726.9719.5413.329.24-
Upgrade
Operating Income
-25.27-26.97-19.54-13.32-9.24-
Upgrade
Interest & Investment Income
1.51.5----
Upgrade
Other Non Operating Income (Expenses)
-0.43-0.190.480.55-0.04-
Upgrade
EBT Excluding Unusual Items
-24.2-25.65-19.07-12.77-9.28-
Upgrade
Legal Settlements
---1.7---
Upgrade
Other Unusual Items
--6.88---
Upgrade
Pretax Income
-24.2-25.65-13.89-12.77-9.28-
Upgrade
Earnings From Continuing Operations
--25.65-13.89-12.77-9.28-
Upgrade
Net Income
-24.2-25.65-13.89-12.77-9.28-7.21
Upgrade
Net Income to Common
-24.2-25.65-13.89-12.77-9.28-
Upgrade
Shares Outstanding (Basic)
5251383310-
Upgrade
Shares Outstanding (Diluted)
5251383310-
Upgrade
Shares Change (YoY)
15.66%32.98%15.56%234.38%--
Upgrade
EPS (Basic)
-0.46-0.50-0.36-0.39-0.94-
Upgrade
EPS (Diluted)
-0.46-0.50-0.36-0.39-0.94-
Upgrade
Free Cash Flow
-21.52-24.59-19.13-11.52-7.77-
Upgrade
Free Cash Flow Per Share
-0.41-0.48-0.50-0.35-0.79-
Upgrade
EBITDA
-24.9-26.61-19.16-12.98-8.89-
Upgrade
D&A For EBITDA
0.370.360.380.350.35-
Upgrade
EBIT
-25.27-26.97-19.54-13.32-9.24-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.